在胃癌的新辅助疗法中应用病理反应率的前景
Zicheng Bao1, Nan Jia1, Zhidong Zhang1
1The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Frontiers in oncology
|April 28, 2025
概括
包括免疫疗法在内的新辅助疗法,通过缩小瘤和改善外科手术结果,对局部晚期胃癌具有前途. 这种方法为面临有限生存选择的患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 手术瘤学手术瘤学
背景情况:
- 胃癌的发病率和死亡率正在上升,构成严重的全球健康威胁.
- 大多数患者 (约. 80%的中国人) 被诊断出本地已晚期的疾病,往往无法接受治疗性手术.
- 目前的息治疗提供了有限的生存率,突出了改善治疗策略的必要性.
研究的目的:
- 审查手术前新辅助疗法在局部晚期胃癌中的作用和疗效.
- 在新辅助治疗方案中探索新型免疫疗法的潜力.
- 评估新辅助疗法对瘤下降阶段和手术切除能力的影响.
主要方法:
- 对研究胃癌新辅助疗法的临床试验的综述.
- 对瘤大小减小和淋巴结状况的数据分析后的治疗.
- 在结合新辅助方法的研究中评估复发率和生存结果.
主要成果:
- 手术前的新辅助疗法有效地减少了瘤大小和淋巴结负担.
- 这种下降阶段改善了R0切除 (完全切除瘤) 的速度.
- 新辅助治疗还降低了瘤细胞的活动,并消除了微转移,可能降低复发率.
结论:
- 新辅助疗法是局部晚期胃癌的有希望的策略,提高了手术结果.
- 免疫疗法的整合代表了新辅助治疗选择的重大进步.
- 对新辅助疗法的进一步研究对于改善胃癌患者的生存率至关重要.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...